Namwiwat Medical Corporation Past Earnings Performance
Past criteria checks 2/6
Namwiwat Medical has been growing earnings at an average annual rate of 13.4%, while the Medical Equipment industry saw earnings growing at 9% annually. Revenues have been declining at an average rate of 12.2% per year. Namwiwat Medical's return on equity is 8.5%, and it has net margins of 16.7%.
Key information
13.4%
Earnings growth rate
-60.0%
EPS growth rate
Medical Equipment Industry Growth | 12.3% |
Revenue growth rate | -12.2% |
Return on equity | 8.5% |
Net Margin | 16.7% |
Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses Breakdown
How Namwiwat Medical Corporation makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Mar 24 | 1,007 | 168 | 240 | 0 |
31 Dec 23 | 1,103 | 201 | 230 | 0 |
30 Sep 23 | 1,239 | 242 | 152 | 0 |
31 Dec 22 | 1,100 | 176 | 103 | 0 |
31 Dec 21 | 995 | 175 | 115 | 0 |
31 Dec 20 | 679 | 112 | 65 | 0 |
Quality Earnings: NAM-F has high quality earnings.
Growing Profit Margin: NAM-F's current net profit margins (16.7%) are lower than last year (17.2%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: NAM-F's earnings have grown by 13.4% per year over the past 5 years.
Accelerating Growth: NAM-F's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: NAM-F had negative earnings growth (-15%) over the past year, making it difficult to compare to the Medical Equipment industry average (0.9%).
Return on Equity
High ROE: NAM-F's Return on Equity (8.5%) is considered low.